167 related articles for article (PubMed ID: 9277043)
1. Immune mechanism of aplastic anemia.
Nakao S
Int J Hematol; 1997 Aug; 66(2):127-34. PubMed ID: 9277043
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia.
Nakao S; Takami A; Takamatsu H; Zeng W; Sugimori N; Yamazaki H; Miura Y; Ueda M; Shiobara S; Yoshioka T; Kaneshige T; Yasukawa M; Matsuda T
Blood; 1997 May; 89(10):3691-9. PubMed ID: 9160674
[TBL] [Abstract][Full Text] [Related]
3. Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia.
Zeng W; Nakao S; Takamatsu H; Yachie A; Takami A; Kondo Y; Sugimori N; Yamazaki H; Miura Y; Shiobara S; Matsuda T
Blood; 1999 May; 93(9):3008-16. PubMed ID: 10216097
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a CD4+ T cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated aplastic anemia.
Nakao S; Takamatsu H; Yachie A; Itoh T; Yamaguchi M; Ueda M; Shiobara S; Matsuda T
Exp Hematol; 1995 May; 23(5):433-8. PubMed ID: 7720814
[TBL] [Abstract][Full Text] [Related]
5. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia.
Nakao S; Takamatsu H; Chuhjo T; Ueda M; Shiobara S; Matsuda T; Kaneshige T; Mizoguchi H
Blood; 1994 Dec; 84(12):4257-61. PubMed ID: 7994040
[TBL] [Abstract][Full Text] [Related]
6. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
[TBL] [Abstract][Full Text] [Related]
7. Analysis of T-cell clonality in bone marrow of patients with acquired aplastic anaemia.
Melenhorst JJ; Fibbe WE; Struyk L; van der Elsen PJ; Willemze R; Landegent JE
Br J Haematol; 1997 Jan; 96(1):85-91. PubMed ID: 9012692
[TBL] [Abstract][Full Text] [Related]
8. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.
Plasilova M; Risitano A; Maciejewski JP
Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.
Dao AT; Yamazaki H; Takamatsu H; Sugimori C; Katagiri T; Maruyama H; Zaimoku Y; Maruyama K; Ly TQ; Espinoza L; Nakao S
Ann Hematol; 2016 Apr; 95(5):771-81. PubMed ID: 26968551
[TBL] [Abstract][Full Text] [Related]
10. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
[TBL] [Abstract][Full Text] [Related]
11. Severe aplastic anemia with autoimmune thyroiditis showing no hematological response to intensive immunosuppressive therapy.
Tomonari A; Tojo A; Iseki T; Ooi J; Hase H; Shirafuji N; Tani K; Asano S
Acta Haematol; 2003; 109(2):90-4. PubMed ID: 12624493
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immune manifestations between refractory cytopenia of childhood and aplastic anemia in children: A single-center retrospective study.
Wu J; Cheng Y; Zhang L
Leuk Res; 2015 Dec; 39(12):1347-52. PubMed ID: 26427728
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia.
Ren J; Hou XY; Ma SH; Zhang FK; Zhen JH; Sun L; Sun YX; Hao YL; Cheng YF; Hou M; Xu CG; Zhang MH; Peng J
J Intern Med; 2014 Nov; 276(5):512-24. PubMed ID: 24528288
[TBL] [Abstract][Full Text] [Related]
14. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
Huang YL; Huang SL; Huang K; Bao R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.
Feng X; Lin Z; Sun W; Hollinger MK; Desierto MJ; Keyvanfar K; Malide D; Muranski P; Chen J; Young NS
Haematologica; 2017 Oct; 102(10):1691-1703. PubMed ID: 28729300
[TBL] [Abstract][Full Text] [Related]
16. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia.
Shi J; Ge M; Lu S; Li X; Shao Y; Huang J; Huang Z; Zhang J; Nie N; Zheng Y
Blood; 2012 Aug; 120(8):1624-32. PubMed ID: 22797698
[TBL] [Abstract][Full Text] [Related]
18. Immune pathophysiology of aplastic anemia.
Maciejewski JP; Risitano A; Kook H; Zeng W; Chen G; Young NS
Int J Hematol; 2002 Aug; 76 Suppl 1():207-14. PubMed ID: 12430855
[TBL] [Abstract][Full Text] [Related]
19. [Immune pathophysiology of acquired aplastic anemia].
Ishiyama K
Rinsho Ketsueki; 2016 May; 57(5):525-30. PubMed ID: 27263775
[TBL] [Abstract][Full Text] [Related]
20. Proliferation and apoptosis of bone marrow CD4(+) T cells in patients with aplastic anemia and impacts of the secreted cytokines on hematopoietic stem cells from umbilical cord blood.
Zheng M; Sun H; Zhou J; Xu H; Huang L; Liu W
J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):37-41. PubMed ID: 20155453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
